Testosterone vs Trenbolone: complete comparison (potency, effects, dosing)

Quand choisir testosterone

Testosterone remains the universal choice: it is the only molecule recommended for a first cycle, and the only one that should be present in almost all protocols. It covers complete androgenic function (libido, energy, mood, bone density) that other compounds cannot ensure alone. The Bhasin 1996 NEJM RCT demonstrates +6.1 kg lean mass at 600 mg/week over 10 weeks — a well-documented efficacy standard, with a linear dose-response window up to 300 mg/week then plateau (Bhasin 2001). Choose testosterone alone for a first cycle, or as the base of any stack. Its safety profile remains the best documented (Endocrine Society 2018), its kinetics predictable (enanthate or cypionate: half-life 4-8 days, 1-2 injections per week), and the consequent PCT codified (clomid or nolvadex 4-6 weeks, hCG as bridge per Rahnema 2014). Aromatization remains its main drawback at supraphysiological doses: a modulated AI dose (anastrozole 0.5 mg 2-3× per week) is usually enough to keep E2 in the optimal 80-150 pmol/L window. For users sensitive to water retention, estrogen management is necessary beyond 400 mg/week.

Quand choisir trenbolone

Trenbolone is the most potent molecule in the mainstream androgen arsenal: Yarrow 2011 demonstrated in the orchiectomized rat a tissue-selective anabolic activity (muscle, bone preserved, prostate spared, hemoglobin stable) superior to supraphysiological testosterone. Its potency per mg means that at 200 mg/week, it already produces gains comparable to 600 mg/week of pure testosterone — but this potency comes with a unique toxicity profile (Pope 2014, Endocrine Society): HDL collapse often beyond 50%, hypertension, debilitating night sweats, insomnia, accentuated aggression, dose-dependent nephrotoxicity, and progestogenic activity that can induce gynecomastia without aromatization. Reserve it for advanced users who have already done 3-4 clean testosterone cycles, in short cycles (8-10 weeks maximum) with tight monitoring (lipids mid-cycle, weekly BP, creatinine). Never as a beginner cycle, never without a testosterone base (trenbolone alone causes severe libido drop due to lack of complete androgenic profile), never in long cycle. The risk/benefit ratio is only justified in contest prep or competition.

Combinaison ?

The testo + trenbolone combo is one of the most effective and most dangerous stacks. Classic scheme: enanthate 300-400 mg/week + trenbolone acetate 50 mg EOD (175 mg/week) or enanthate 200 mg/week over 8-10 weeks. The testo serves as androgenic base (tren alone causes erectile dysfunction due to incomplete androgenic profile), at moderate dose to limit cumulative aromatization. No strong AI is needed as long as testo dose stays contained; a mild AI is enough (anastrozole 0.5 mg 2× per week). Mandatory monitoring: weekly home BP, lipids every 4 weeks with HDL and apoB, creatinine and eGFR, prolactin if signs of progestogenicity (breast sensitivity, discharge). Regular cardio (zone 2, 30-45 min × 3-4 times per week) is mandatory to counter cardiovascular degradation (Baggish 2017). Classic PCT started 2 weeks after the last tren acetate (or 3 weeks after tren enanthate), with hCG 1500 IU EOD × 10 days then SERM 4-6 weeks. A clean nutritional block (calories +300 to +500 vs maintenance, protein 2.2 g/kg) maximizes gains despite the moderate dose. Sample experienced-user timeline: W0 baseline complete panel (CBC, CMP, lipids, T total/free, E2, PRL), W2 first BP check, W4 E2 measurement and AI titration, W5 mid-cycle full panel (lipids critical), W8 last injection, W10 PCT start, W17 post-PCT recovery confirmation. Sleep architecture warning: trenbolone disrupts REM sleep in most users from week 1 — magnesium glycinate 400 mg + apigenin 50 mg at bedtime improves outcomes modestly. Hydration target: 4 L/day minimum due to combined nephrotoxicity signal and water loss via night sweating. Independent lab testing recommended for tren acetate due to common underground mislabeling rates.